期刊文献+

顶空毛细管GC法测定匹多莫德原料药中6种溶剂的残留量 被引量:1

Determination of 6 kinds of residual solvents in pidotimod raw material by headspace capillary gas chromatography
下载PDF
导出
摘要 目的:建立匹多莫德原料药中6种溶剂残留量的测定方法。方法:采用顶空毛细管气相色谱法,色谱柱为DB-624毛细管柱(30m×0.32mm,1.8μm),FID检测器,进样口温度为200℃,检测器温度为250℃;起始温度为60℃,维持5min,以20℃/min的速率升温至170℃,维持4min;顶空瓶平衡温度为80℃,平衡时间为15min。结果:在该色谱条件下,6种溶剂均能得到良好分离;6种溶剂的线性相关系数均大于0.999;精密度、重复性和稳定性试验的RSD均符合规定;6种溶剂的加样回收率均在92%~105%之间(RSD<10%,n=9)。结论:该方法操作简便,重复性高,结果稳定可靠,可用于匹多莫德残留溶剂的检测。 Objective: To detect the solvent residues in pidotimod raw material, we established a gas chromatography method for determination of 6 kinds of residual solvents. Methods: Headspace capillary gas chromatography was used with DB-624 capillary column(30 m×0.32 mm, 1.8 μm), and FID detector was used for solvent residues detection. The injector temperature was set at 200 ℃, and the detector temperature was set at 250 ℃. The initial column temperature was 60 ℃(maintained for 5 min), and the temperature was increased to 170 ℃(maintained for 4 min) at the rate of 20 ℃/min. The sample was extracted at 80 ℃ for 15 min. Results: Under above chromatographic conditions, all the six residual solvents were well separated, and the linear correlation coefficients of the six residual solvents were all greater than 0.999. RSD values of precision, repeatability and stability test were all in accordance with Pharmacopoeia requirements, and the recoveries of the six residual solvents were between 92% and 105%(RSD<10%, n=9). Conclusion: The established method is simple, reproducible, stable and reliable, and can be used for detection of residual solvents in pidotimod raw material.
作者 王玉霞 郝桂明 王卫 Wang Yuxia;Hao Guiming;Wang Wei(Tianjin Institute for Drug Control,Tianjin 300070)
出处 《天津药学》 2019年第3期9-12,共4页 Tianjin Pharmacy
关键词 匹多莫德 GC 残留溶剂 pidotimod gas chromatography residual solvents
  • 相关文献

参考文献3

二级参考文献19

  • 1田新平,曾小峰.新型合成免疫调节剂——匹多莫德[J].中国新药杂志,2005,14(1):111-114. 被引量:97
  • 2李一平,蔡辉,顾远晖,李渊.匹多莫德对慢性丙型肝炎患者免疫功能的影响[J].兰州大学学报(医学版),2006,32(1):33-34. 被引量:3
  • 3安鲁凡,单世明,余书勤.匹多替莫[J].中国新药杂志,1997,6(2):110-111. 被引量:16
  • 4di Marco R.Condorelli F.Girardello R,et al.Increased rate of survival in Streptococcus pneumoniae-infected rats treated with the new immunomodulator pidotimod. Scandinavian Journal of Infectious Diseases . 1992
  • 5F Capsoni,F Minonzio,A Mongari,et al.Evaulation of the kinetics of the imunomodulation activity of pidotimod on human. Neutrophils pharmacol, Res . 1992
  • 6QI X L,WANG L S,ZHU J B.Water-In-Oil-In-Water double e-mulsions:An excellent delivery system for improving the oral bio-availability of pidotimod in rats. Journal of Pharmacological Sciences . 2011
  • 7Mailland,Coppi,Silingardi.Pharmacokinetics and oral bioavailability of pidotimod in humans. Arzneim.-Forsch./Drug Res . 1994
  • 8Taramelli D,Malabarba MG,Basilico N,et al.Effects of pidotimod on macrophage functions in methylprednisolone-treated mice. Arzneimittelfors . 1994
  • 9D’’Angelo L,De Ponti F,Crema Fet al.Effect of food on the bio-availability of pidotimod in healthy volunteers. Arzneimittelfors-chung . 1994
  • 10PassaliD,CalearoC,ConticelloS.Pidotimodinthemanage-mentofrecurrentpharyngotonsillarinfectionsinchildhood. Arzneimittelfors . 1994

共引文献119

同被引文献19

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部